Scott Bussom
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Flavonoids in Medical Research
-
- Traditional Chinese Medicine Analysis
Papers in
- Oncology 6
- Pancreatic and Hepatic Oncology Research 4
- Cancer-related Molecular Pathways 2
-
- RNA modifications and cancer 2
- DNA Repair Mechanisms 1
- Co-authors
- Wing Lam (7 shared papers)Yung‐Chi Cheng (8 shared papers)Zaoli Jiang (6 shared papers)Fulan Guan (4 shared papers)Shwu-Huey Liu (3 shared papers)Elizabeth A. Gullen (2 shared papers)Wei Zhang (1 shared paper)Muhammad Wasif Saif (4 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Molecular Pharmacology (1 paper)BMC Medical Genomics (1 paper)DNA repair (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Scott Bussom
14 papers receiving 737 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 144
- Complementary and alternative medicine 116
- Pharmacology 118
- Toxicology 19
- Oncology 133
Countries citing papers authored by Scott Bussom
This map shows the geographic impact of Scott Bussom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bussom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bussom more than expected).
Fields of papers citing papers by Scott Bussom
This network shows the impact of papers produced by Scott Bussom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bussom. The network helps show where Scott Bussom may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Bussom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 287 | |
| 2 | 2015 | 95 | |
| 3 | 2010 | 72 | |
| 4 | 2007 | 71 | |
| 5 | 2013 | 61 | |
| 6 | 2011 | 61 | |
| 7 | 2009 | 30 | |
| 8 | Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. | 2010 | 27 |
| 9 | 2009 | 20 | |
| 10 | 2007 | 12 | |
| 11 | Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. | 2010 | 4 |
| 12 | 2010 | 4 | |
| 13 | 2010 | 4 | |
| 14 | Abstract #4584: Exploration of the mechanisms of PHY906 in reducing the intestinal toxicity caused by irinotecan | 2009 | 2 |
About Scott Bussom
Scott Bussom is a scholar working on Oncology, Molecular Biology, Cancer Research, Pharmacology and Surgery, having authored 14 papers that have together received 750 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer-related Molecular Pathways (2 papers), Flavonoids in Medical Research (2 papers), RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), DNA Repair Mechanisms (1 paper), Cancer Genomics and Diagnostics (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Pharmacology (144 citations), Complementary and alternative medicine (116 citations), Pharmacology (118 citations), Toxicology (19 citations) and Oncology (133 citations). Scott Bussom has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Wing Lam, Yung‐Chi Cheng, Zaoli Jiang, Fulan Guan, Shwu-Huey Liu, Elizabeth A. Gullen, Wei Zhang, Muhammad Wasif Saif, Yung-Chi Cheng and Rong Hu. Their work appears in journals such as Journal of Clinical Oncology, Molecular Pharmacology, BMC Medical Genomics, DNA repair and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.